Human MEPE/OF45 Antibody

Catalog # Availability Size / Price Qty
MAB3140
MAB3140-SP
Product Details
FAQs
Supplemental Products
Reviews

Human MEPE/OF45 Antibody Summary

Species Reactivity
Human
Specificity
Detects human MEPE/OF45 in direct ELISAs and Western blots.
Source
Monoclonal Mouse IgG1 Clone # 341611
Purification
Protein A or G purified from hybridoma culture supernatant
Immunogen
Mouse myeloma cell line NS0-derived recombinant human MEPE/OF45
Pro18-Asp525
Accession # Q9NQ76
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Applications

Recommended Concentration
Sample
Western Blot
1 µg/mL
Recombinant Human MEPE (Catalog # 3140-ME)

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: MEPE/OF45

MEPE (matrix extracellular phosphoglycoprotein), known as OF45 in mouse and rat, is a 55 kDa member of the SIBLING protein family. MEPE is primarily expressed in bone and dentin, where it regulates the mineralization of those tissues (1‑3). The human MEPE cDNA encodes a 525 amino acid (aa) precursor that includes a 17 aa signal sequence. MEPE contains multiple consensus sites for post-translational modifications, including N-linked glycosylation, N-myristoylation, glycosaminoglycan attachment, and phosphorylation by a variety of kinases. MEPE also contains several putative proteolytic cleavage sites and one integrin-binding RGD motif (3, 4). There is therefore considerable potential for post-translational regulation of MEPE function and its degradation products. MEPE is secreted by osteoblasts and dental pulp stem cells during the mineralization process (5‑7) and also by nonmineralizing tissues including epithelial cells in the renal proximal tubule and salivary duct (8, 9). MEPE has an inhibitory function in bone formation, (5) although a peptide corresponding to aa 242‑264 stimulates new bone formation and the proliferation of osteoblasts and dental pulp stem cells (10, 11). MEPE contains one C‑terminal ASARM motif common to SIBLING proteins. Similar to intact MEPE, the ASARM peptide inhibits bone mineralization and plays a central role in the phosphaturia and reduced mineralization of X-linked hypophosphatemic rickets (HYP) and tumor‑induced osteomalacia (TIO) (12, 13). The zinc metalloprotease Phex binds directly to MEPE via the ASARM motif and prevents ASARM cleavage (13, 14). Multiple inactivating mutations in Phex are found in HYP and TIO and result in the increased liberation of ASARM peptide (15). Both MEPE and ASARM peptide are elevated in these disorders of mineralization and phosphate metabolism (12).

References
  1. Fisher, L.W. and N.S. Fedarko (2003) Connect. Tiss. Res. 44:33.
  2. Quarles, L.D. (2003) Am. J. Physiol. 285:E1.
  3. Qin, C. et al. (2004) Crit. Rev. Oral Biol. Med. 15:126.
  4. Rowe, P.S.N. et al. (2000) Genomics 67:54.
  5. Gowen, L.C. et al. (2003) J. Biol. Chem. 278:1998.
  6. Siggelkow, H. et al. (2004) Bone 35:570.
  7. Liu, H. et al. (2005) Arch. Oral Biol. 50:923.
  8. Ogbureke, K.U.E. and Fisher, L.W. (2005) Kidney Int. 68:155.
  9. Ogbureke, K.U.E. and L.W. Fisher (2004) J. Dent. Res. 83:664.
  10. Hayashibara, T. et al. (2004) J. Bone Miner. Res. 19:455.
  11. Liu, H. et al. (2004) J. Dent. Res. 83:496.
  12. Bresler, D. et al. (2004) J. Endocrinol. 183:R1.
  13. Rowe, P.S.N. et al. (2005) Bone 36:33.
  14. Guo, R. et al. (2002) Biochem. Biophys. Res. Commun. 297:38.
  15. Rowe, P.S. (2004) Crit. Rev. Oral Biol. Med.15:264.
Long Name
Matrix Extracellular Phosphoglycoprotein with ASARM Motif
Entrez Gene IDs
56955 (Human); 94111 (Mouse); 79110 (Rat)
Alternate Names
extracellular phosphoglycoprotein with ASARM motif (bone); matrix extracellular phosphoglycoprotein; MEPE; OF45; Osteoregulin

Product Datasheets

You must select a language.

x

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Human MEPE/OF45 Antibody

There are currently no reviews for this product. Be the first to review Human MEPE/OF45 Antibody and earn rewards!

Have you used Human MEPE/OF45 Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review